Tony Fitzgerald practiced law before moving into business, initially through the wine sector and then the life sciences sector where he has undertaken various technology licensing and collaborative research transactions and company startups.
Mr Fitzgerald has studied and worked in Australia, Japan, North America and Europe; and served on the boards of public and private companies in areas including cancer immunology, medical imaging, pharmaceutical distribution and cardiac AI.
He has extensive experience in the listed sector, having been a director of Inovax and Geo2 which became Resonance Health, and executive chair of Regenera when the company changed to Advanced Ocular Systems after buying a US technology group by that name. In the corporate area of tax-effective investment
Mr Fitzgerald was a director of Southern Wine Corporation, the company behind the Preston Vale Vineyard project at Donnybrook. He was also director of other wine-related companies Nelson Ridge Holdings (in 2000) and Diamond Ridge Holdings (in late 1999 and early 2000).
Prior to founding Selvax in 2014 Mr FItzgerald was a director of Steel Minerals, a Perth-based subsidiary of UK-based Steelmin which is a private resource investment company targeting production of strategic alloys connected to steel manufacture. He also co-founded Alerte Digital Health in 2014 which uses medical and physiological data to provide early health warning systems; and Avicena Systems in 2020 which offers innovative testing technology to identify COVID-19, dengue fever, tuberculosis and malaria.
